-

KBRA Releases Research – KBRA CMBS Loss Compendium Update: June 2024

NEW YORK--(BUSINESS WIRE)--KBRA releases the June 2024 issue of the KBRA CMBS Loss Compendium, which provides loss estimates for all KBRA-rated conduit transactions. In this report and its accompanying spreadsheet, KBRA provides insight into loss estimates for 343 outstanding transactions and includes lifetime realized losses for eight conduits with withdrawn ratings owing to payoffs.

The compendium uses the following two metrics to present the loss figures: KBRA Lifetime Base Loss (KLBL), which represents our loss estimate for each transaction during its lifetime as a percentage of its original balance; and KBRA Future Base Loss (KFBL), which represents potential future losses as a percentage of outstanding deal balance as of the most recent rating action date.

As of June 2024, the average KLBL (as a % of original deal balance) is 5% (ranging from 1.7% to 17.7%), which increased for the second consecutive period, from the December 2023 and June 2023 figures of 4.8% and 4.7%, respectively. The average KFBL (as a % of review date deal balance) is 8.4% (ranging from 2.7% to 81.8%), which witnessed the highest period-over-period increase, up from 6.8% in December 2023 and 6.3% in June 2023.

Click here to view the report.

Related Publications

About KBRA

KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Doc ID: 1005035

Contacts

Neel Munot, Director
+1 646-731-1215
neel.munot@kbra.com

Roy Chun, Senior Managing Director
+1 646-731-2376
roy.chun@kbra.com

Nitin Bhasin, Senior Managing Director, Global Head of CMBS
+1 646-731-2334
nitin.bhasin@kbra.com

Business Development

Daniel Stallone, Managing Director
+1 646-731-1308
daniel.stallone@kbra.com

Kroll Bond Rating Agency, LLC

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Neel Munot, Director
+1 646-731-1215
neel.munot@kbra.com

Roy Chun, Senior Managing Director
+1 646-731-2376
roy.chun@kbra.com

Nitin Bhasin, Senior Managing Director, Global Head of CMBS
+1 646-731-2334
nitin.bhasin@kbra.com

Business Development

Daniel Stallone, Managing Director
+1 646-731-1308
daniel.stallone@kbra.com

Social Media Profiles
More News From Kroll Bond Rating Agency, LLC

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%. KBR...

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...
Back to Newsroom